ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,558 | +31.7% | 471 | +4.4% | 0.01% | +33.3% |
| Q2 2023 | $175,768 | +7.5% | 451 | +2.7% | 0.01% | 0.0% |
| Q1 2023 | $163,563 | +0.4% | 439 | +2.1% | 0.01% | -14.3% |
| Q4 2022 | $162,897 | +17.2% | 430 | +9.4% | 0.01% | +16.7% |
| Q3 2022 | $139,000 | +8.6% | 393 | +16.6% | 0.01% | 0.0% |
| Q2 2022 | $128,000 | +37.6% | 337 | +13.9% | 0.01% | +50.0% |
| Q1 2022 | $93,000 | -30.6% | 296 | -22.7% | 0.00% | -20.0% |
| Q4 2021 | $134,000 | +235.0% | 383 | +185.8% | 0.01% | +150.0% |
| Q3 2021 | $40,000 | +135.3% | 134 | +143.6% | 0.00% | +100.0% |
| Q2 2021 | $17,000 | 0.0% | 55 | -12.7% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | +142.9% | 63 | +162.5% | 0.00% | – |
| Q4 2020 | $7,000 | +250.0% | 24 | +200.0% | 0.00% | – |
| Q3 2020 | $2,000 | -75.0% | 8 | -86.9% | 0.00% | -100.0% |
| Q1 2020 | $8,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |